Novelion Therapeutics ($NVLN) announced receiving approval from the Toronto Stock Exchange for its request to delist effective at the market close on May 3. The company took the decision due to low trading volume on the exchange. The stock will keep trading on the Nasdaq Global Select Market.
NuVasive ($NUVA) announced the commercial launch of its RELINE Trauma system, a portfolio of products targeted to the spine trauma fixation market. The system lets the surgeons customize their approach during surgery, including open, maximum access surgery (MAS) or hybrid procedures.